# Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts

> **NCT01943630** · PHASE2 · UNKNOWN · sponsor: **BioMAS Ltd** · enrollment: 60 (estimated)

## Conditions studied

- External Genital Warts

## Interventions

- **DRUG:** 15% AS101 gel
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01943630
- **Lead sponsor:** BioMAS Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01943630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01943630, "Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01943630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*